IGC Pharma (IGC) Other Working Capital Changes (2016 - 2025)
IGC Pharma has reported Other Working Capital Changes over the past 16 years, most recently at -$1.1 million for Q3 2025.
- Quarterly Other Working Capital Changes fell 544.91% to -$1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$843000.0 through Sep 2025, down 620.51% year-over-year, with the annual reading at $187000.0 for FY2025, 244.96% up from the prior year.
- Other Working Capital Changes was -$1.1 million for Q3 2025 at IGC Pharma, down from -$2000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.2 million in Q1 2021 and troughed at -$1.1 million in Q3 2025.
- The 5-year median for Other Working Capital Changes is -$28000.0 (2023), against an average of $2368.4.
- Year-over-year, Other Working Capital Changes skyrocketed 1603.88% in 2021 and then crashed 1725.0% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $36000.0 in 2021, then crashed by 438.89% to -$122000.0 in 2022, then skyrocketed by 74.59% to -$31000.0 in 2023, then surged by 870.97% to $239000.0 in 2024, then tumbled by 550.63% to -$1.1 million in 2025.
- Per Business Quant, the three most recent readings for IGC's Other Working Capital Changes are -$1.1 million (Q3 2025), -$2000.0 (Q2 2025), and -$3000.0 (Q1 2025).